| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/30/2014 | CN102838675B Ip-10抗体及其用途 Ip-10 antibodies and uses thereof |
| 07/30/2014 | CN102590515B 艰难梭菌外毒素a检测试剂盒及组成该试剂盒的单克隆抗体 Detection of Clostridium difficile toxin a kit and the kit composed of monoclonal antibodies |
| 07/30/2014 | CN102373215B 具有增加的Fc受体结合亲和性和效应子功能的CD20抗体 Having increased Fc receptor binding affinity and effector function CD20 antibody |
| 07/30/2014 | CN102326075B 纤维素类凝胶、填充剂及填充剂的制法、免疫球蛋白制剂的制法 Cellulose-based gel filler, and the filler preparation method, the immunoglobulin formulation is prepared by |
| 07/30/2014 | CN102209727B 抗TGF-β受体II抗体 Anti-TGF-β receptor II antibody |
| 07/30/2014 | CN102170906B 靶定补体蛋白c5的抗体的组合物和方法 Compositions and methods of targeting antibodies to complement proteins c5 |
| 07/30/2014 | CN102046196B 用于选择患者的生物标志物及相关方法 Patient selection biomarker and related methods for |
| 07/30/2014 | CN101969929B 粉末状蛋白质组合物及其制备方法 Powdered protein composition and preparation method |
| 07/30/2014 | CN101885770B 一种特异性结合cd15的全人源抗体及应用 One kind of specific binding cd15 fully human antibodies and application |
| 07/30/2014 | CN101868250B 包含hcmv颗粒的组合物 The composition comprises particles hcmv |
| 07/30/2014 | CN101842115B 人源化的抗-cxcr5抗体、其衍生物及它们的应用 Humanized anti -cxcr5 antibodies, their derivatives and their applications |
| 07/30/2014 | CN101730544B Pitman moore狂犬病病毒株对原代鸡胚成纤维细胞培养物的适应方法 Pitman moore rabies virus strains into primary chick embryo fibroblast culture adaptation of |
| 07/30/2014 | CN101516394B 制备抗耐药性抗原的活性抗体的方法、所述方法获得的抗体及其用途 Preparation of anti-resistance activity of the antigen antibody, an antibody obtained by said method and uses thereof |
| 07/30/2014 | CN101432305B 运铁蛋白受体抗体 Transferrin receptor antibody |
| 07/29/2014 | USRE45053 Attenuated dengue virus comprising mutations in the NS3 gene |
| 07/29/2014 | US8791252 Therapy-enhancing glucan |
| 07/29/2014 | US8791243 Treatment and prophylaxis of amyloidosis |
| 07/29/2014 | US8791242 Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms |
| 07/29/2014 | US8791233 Maspin-based peptides and methods of use thereof |
| 07/29/2014 | US8791074 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 07/29/2014 | US8791062 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 07/29/2014 | US8790934 Nanoparticles |
| 07/29/2014 | US8790910 Live vaccine strain |
| 07/29/2014 | US8790893 Measuring degree of polymerisation for meningococcal capsular saccharides that contain sialic acid |
| 07/29/2014 | US8790883 Methods of identifying NF-κB inhibitors |
| 07/29/2014 | US8790882 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/29/2014 | US8790872 Non-elispot assay |
| 07/29/2014 | US8790695 Medicinal carriers, and preparation method and uses thereof |
| 07/29/2014 | US8790665 Serum protein-based detection of random sequence polymer compositions |
| 07/29/2014 | US8790662 Methods for treating refractory infections in neutropenic individuals |
| 07/29/2014 | US8790661 Exosomes derived from reticulocytes infected with Plasmodium sp., method for obtaining them and uses thereof |
| 07/29/2014 | US8790660 Vaccine against Ehrlichia canis |
| 07/29/2014 | US8790659 SlpA as a tool for recombinant protein and enzyme technology |
| 07/29/2014 | US8790658 Antigen-adjuvant compositions and methods |
| 07/29/2014 | US8790657 Astrovirus |
| 07/29/2014 | US8790656 PRRSV vaccines |
| 07/29/2014 | US8790655 Conjugates of synthetic TLR agonists and uses therefor |
| 07/29/2014 | US8790654 Glycosylceramide adjuvant for saccharide antigens |
| 07/29/2014 | US8790653 Peptide inhibitors for mediating stress responses |
| 07/29/2014 | US8790652 Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis |
| 07/29/2014 | US8790651 Interleukin-31 monoclonal antibody |
| 07/29/2014 | US8790650 Methods of using an antibody to inhibit WNT-mediated cardiac remodeling |
| 07/29/2014 | US8790649 EGFR-binding molecules and immunoconjugates thereof |
| 07/29/2014 | US8790648 Methods of treating psoriasis using IL-17 receptor A antibodies |
| 07/29/2014 | US8790647 Treatment of vasculoproliferative conditions with Lrg1 anatgonists |
| 07/29/2014 | US8790646 Compositions and methods for modulating vascular development |
| 07/29/2014 | US8790645 Pharmaceutical composition comprising a bispecific antibody for EpCAM |
| 07/29/2014 | US8790644 Humanized antibodies that recognize alpha-synuclein |
| 07/29/2014 | US8790643 Methods for treating disease using an anti-IL-21 receptor antibody |
| 07/29/2014 | US8790642 Cross-reactive and bispecific anti-IL-17A/F antibodies |
| 07/29/2014 | CA2718812C Porcine adenovirus type 3 genome |
| 07/29/2014 | CA2691033C Capsid proteins and uses therefore |
| 07/29/2014 | CA2685270C Expression vectors for stimulating an immune response and methods of using the same |
| 07/29/2014 | CA2592249C Binding proteins specific for human matriptase |
| 07/29/2014 | CA2537161C Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 07/29/2014 | CA2518669C Purification process |
| 07/29/2014 | CA2494974C Il-7 drug substance, composition, preparation and uses |
| 07/29/2014 | CA2489052C Infectious cdna of an approved vaccine strain of measles virus, use for immunogenic compositions |
| 07/29/2014 | CA2455365C Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 07/24/2014 | WO2014113820A1 Estrogen receptor inhibitors |
| 07/24/2014 | WO2014113802A1 TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS |
| 07/24/2014 | WO2014113541A1 Attenuated chlamydia vaccine |
| 07/24/2014 | WO2014113490A2 Immunogenic wt-1 peptides and methods of use thereof |
| 07/24/2014 | WO2014113436A1 Adenoviruses and their use |
| 07/24/2014 | WO2014112945A1 Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains |
| 07/24/2014 | WO2014111733A1 Composition and uses thereof |
| 07/24/2014 | WO2014111724A1 Glycosylation method |
| 07/24/2014 | WO2014111704A1 Antibodies that bind to jagged 1 |
| 07/24/2014 | WO2014111516A1 Mdr e. coli specific antibody |
| 07/24/2014 | WO2014111207A1 Diagnosis of leishmania infection |
| 07/24/2014 | WO2014086732A3 Reassortant influenza a viren |
| 07/24/2014 | WO2014083567A3 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors |
| 07/24/2014 | WO2014083019A3 Agent for modulating the dissemination of cancer cells, product comprising said agent, and use of said agent in the treatment and/or prevention of cancer |
| 07/24/2014 | WO2014082080A3 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases |
| 07/24/2014 | WO2014081346A3 Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic sendai virus |
| 07/24/2014 | WO2014080015A3 Hair growth compositions and methods |
| 07/24/2014 | WO2014074835A3 Antibody compositions and immunoassay methods to detect isoforms of anti-mullerian hormone |
| 07/24/2014 | US20140207105 Methods for Effectively and Rapidly Desensitizing Allergic Patients |
| 07/24/2014 | US20140206556 Systems and Methods for Identifying Replikin Scaffolds and Uses of Said Replikin Scaffolds |
| 07/24/2014 | US20140206062 Recombinant Influenza Viruses for Vaccines and Gene Therapy |
| 07/24/2014 | US20140205656 Modified cationic liposome adjuvants |
| 07/24/2014 | US20140205653 Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use |
| 07/24/2014 | US20140205652 Novel method and compositions |
| 07/24/2014 | US20140205634 Treatment of streptococcal infections |
| 07/24/2014 | US20140205633 Immunostimulatory oligodeoxynucleotides |
| 07/24/2014 | US20140205632 Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles |
| 07/24/2014 | US20140205631 Stimulation of vaccination by angiotensin peptides |
| 07/24/2014 | US20140205630 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells |
| 07/24/2014 | US20140205629 Tc-83-derived alphavirus vectors, particles and methods |
| 07/24/2014 | US20140205624 Tetravalent and mixed head bivalent dengue vaccine |
| 07/24/2014 | US20140205623 Protein-based streptococcus pneumoniae vaccines |
| 07/24/2014 | US20140205619 Recombinant avian influenza vaccine and uses thereof |
| 07/24/2014 | US20140205617 Compositions and Methods for Treatment of Neoplastic Disease |
| 07/24/2014 | US20140205615 Human cytomegalovirus neutralizing antibodies and use thereof |
| 07/24/2014 | US20140205613 Anti-tnf and anti-il 17 combination therapy biomarkers for inflammatory disease |
| 07/24/2014 | US20140205612 Human immunodeficiency virus (hiv)-neutralizing antibodies |
| 07/24/2014 | US20140205609 Methods for inducing systemic immune responses to cancer |
| 07/24/2014 | US20140205605 Optimized antibodies that target hm1.24 |
| 07/24/2014 | US20140205603 Siglec-15 antibodies in treating bone loss-related disease |
| 07/24/2014 | US20140205602 Antagonist anti-cd40 monoclonal antibodies and methods for their use |